Advertisement

Topics

Bausch & Lomb Incorporated Company Profile

13:48 EST 24th November 2017 | BioPortfolio

Bausch & Lomb is the preeminent global technology based healthcare company for the eye, dedicated to helping consumers see, look and feel better through innovative technology and design. The company is building on that position through expansion of its current eye care businesses, as well as the pursuit of promising new opportunities within the global eye care market.

Bausch & Lomb manages its commercial operations on a regional basis and the research and development and product supply functions are managed on a global basis. The company markets five broad categories of products:



Contact Lenses: Sales of contact lenses represented approximately 28% of consolidated 2001 revenues. The company's contact lens offerings span the entire spectrum of wearing modalities and include such well known brand names as PureVision, SofLens66 Toric, SofLens One Day, Bausch & Lomb Two Week, Boston and Optima FW.

Lens Care: The sale of contact lens care solutions represented approximately 25% of consolidated 2001 revenues. The company’s lens care products include the ReNu and Sensitive Eyes brands for soft contact lenses and the Boston line of products for cleaning rigid gas permeable contact lenses.



Cataract and Vitreoretinal Surgery: Products used for cataract and vitreoretinal surgery procedures accounted for approximately 18% of consolidated 2001 revenues. The company offers a full suite of products in this area, including various intraocular lenses and delivery systems, the Millennium line of phacoemulsification equipment, and other surgical devices and instruments.

Refractive Surgery: Sales of products used in refractive surgery accounted for approximately 8% of consolidated 2001 revenues. Offerings in this area include the Technolas 217 small-beam advanced scanning excimer laser, the Hansatome microkeratome, the Orbscan corneal topographer and, outside the U.S., the Zyoptix system for customized laser vision correction.



Pharmaceutical: Sales of pharmaceutical products accounted for approximately 21% of consolidated 2001 revenues. The company’s offerings include generic and proprietary prescription pharmaceuticals, mostly in the ophthalmic field, over-the-counter eye drops and other medications. During 2000 the company expanded its presence in this area through the acquisition of Groupe Chauvin, a French ophthalmic pharmaceutical company. In combination with the company's existing Dr. Mann Pharma business in Germany, the acquisition will provide a pan-European presence and infrastructure from which to launch new products in development as well as to expand the distribution of the company's current proprietary pharmaceutical products, such as Lotemax and Alrex.

Location

One Bausch & Lomb Place
Rochester
NY
14604
United States of America

Contact

Phone: 716 338 6000


News Articles [77 Associated News Articles listed on BioPortfolio]

Bausch + Lomb Japan Launches Bausch & Lomb AQUALOX Contact Lenses

  Life Sciences Jobs   ...

Bausch & Lomb Stereo Zoom 4 Microscope Stereo-Mikroskop

EUR 60,00 (1 Gebot)Angebotsende: Sonntag Jul-30-2017 11:09:30 CESTJetzt bieten | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Bausch & Lomb Stereo Zoom 4 Microscope Stereo-Mik...

VIDEO: Bausch + Lomb unveils innovations at AAO

NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Chuck Hess, general manager of surgical business for Bausch + Lomb, discusses new technology for the anterior and posterior segments that w...

Bausch+Lomb Facility Inspection Triggers CRL for Valeant

NewsValeant Pharmaceuticals receives complete response letter (CRL) from the FDA for latanoprostene bunod ophthalmic solution, 0.024% NDA. The CRL from the FDA only refers to a cGMP inspection at Baus...

Bausch + Lomb launches Ocuvite Minigels

Bausch + Lomb will launch a daily eye vitamin that helps replenish nutrients that eyes can lose as they age, the company announced in a press release.Ocuvite Adult 50+ Formula Minigels, which include ...

FDA gives nod to Bausch + Lomb’s once-daily glaucoma drops

The FDA has approved the new drug application for the once-daily glaucoma treatment Vyzulta, according to a press release issued jointly by Bausch + Lomb, a subsidiary of Valeant Pharmaceuticals, and ...

Valeant: Bausch & Lomb Is #1 Contact Lenses In China E-Retailing

FDA Okays Treatment For Patients With Glaucoma Or Ocular Hypertension

NewsBausch + Lomb and Nicox announce FDA approval of Vyzulta (latanoprostene bunod ophthalmic solution), 0.024%. Nicox will receive $17.5 million from Bausch + Lomb and will make a $15 million pay...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

A 172 μW Compressively Sampled Photoplethysmographic (PPG) Readout ASIC With Heart Rate Estimation Directly From Compressively Sampled Data.

A compressive sampling (CS) photoplethysmographic (PPG) readout with embedded feature extraction to estimate heart rate (HR) directly from compressively sampled data is presented. It integrates a low-...

Identifying stochastic oscillations in single-cell live imaging time series using Gaussian processes.

Multiple biological processes are driven by oscillatory gene expression at different time scales. Pulsatile dynamics are thought to be widespread, and single-cell live imaging of gene expression has l...

Clinical Trials [19 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens

This study is to evaluate the safety and effectiveness of the Bausch & Lomb Akreos TL intraocular lens following implantation in adults requiring cataract surgery.

Performance of Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution in a New Packaging Configuration

The objective of the study is to evaluate the product performance of Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution in a new packaging configuration

A Study to Evaluate the Clinical Performance of a Novel Multipurpose Solution

The objective of this study is to evaluate the clinical performance of Bausch & Lomb investigational Multi-Purpose Solution compared to Ciba Vision Multi-Purpose Solution when used by wear...

Wavefront Analysis and Contrast Sensitivity After Cataract Surgery With Akreos Advanced Optics Intraocular Lens Implantation

Purpose: To determine whether implantation of an intraocular lens (IOL) with a modified anterior and posterior aspherical surface (Akreos AO, Bausch & Lomb,Inc) results in reduced ocular a...

Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers

This study is being conducted to evaluate Bausch & Lomb PureVision Multi-Focal contact lenses compared to the Bausch & Lomb SofLens59 contact lens when worn by adapted soft contact lens we...

Companies [45 Associated Companies listed on BioPortfolio]

Bausch & Lomb

Bausch & Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pha...

Bausch & Lomb, Inc.

Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life.We offer the world’s most comprehensive portfolio of eye health products and we’re proud that ours is one ...

Bausch + Lomb and Cirle

Bausch + Lomb, a Valeant Pharmaceuticals North America LLC company, is a leading global eye health organization that is solely focused on protecting, enhancing, and restoring peop...

Bausch & Lomb Incorporated

Bausch & Lomb is the preeminent global technology based healthcare company for the eye, dedicated to helping consumers see, look and feel better through innovative technology and design. The company i...

BAUSCH-STROBEL Machine Company, Inc

With this clearly defined company goal in mind, we design, build and sell packaging and production systems for the pharmaceutical, cosmetic and chemical industries. From modest beginnings to 40 years ...

More Information about "Bausch & Lomb Incorporated" on BioPortfolio

We have published hundreds of Bausch & Lomb Incorporated news stories on BioPortfolio along with dozens of Bausch & Lomb Incorporated Clinical Trials and PubMed Articles about Bausch & Lomb Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bausch & Lomb Incorporated Companies in our database. You can also find out about relevant Bausch & Lomb Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...


Corporate Database Quicklinks



Searches Linking to this Company Record